Le Lézard
Classified in: Sports and recreation, Covid-19 virus
Subjects: PDT, MIN

PodcastOne Grows 'SportsNet' Programming With Slate Of New Shows From Super Bowl Champ Michael Irvin, Adam Carolla And Jeff Cesario


LOS ANGELES, Oct. 2, 2020 /PRNewswire/ -- PodcastOne, a subsidiary of LiveXLive Media (Nasdaq: LIVX), is strengthening its sports-based programming network -- SportsNet -- with a slate of new and upcoming programming for 2020. Super Bowl Champion Michael Irvin is lined up for a weekly podcast; World Record-holding podcaster and comedian Adam Carolla and comedian Jeff Cesario will launch the daily "All Balls, All Sports."  Leading sports television host Chris Myers recently debuted his "CMI: The Chris Myers Interview" on PodcastOne's sports network in August 2020 and to date has featured interviews with Urban Meyer, Warren Moon, Jimmy Johnson and Jim Edmonds.

"Sports-related programming has done remarkably well on our network and this slate of premium sports shows from some of the greatest sports and comedic talent will serve both our audience and our advertisers," said Peter Morris, PodcastOne's CEO. 

PodcastOne's SportsNet existing shows includes leading podcasts from NBA great Shaquille O'Neal, legendary boxing champ Mike Tyson, sports journalist Rich Eisen and famed wrestler Steve Austin. Listenership in sports related programming on PodcastOne has increased 14% in Q3 since the end of Q2 in calendar year 2020.

PodcastOne's new SportsNet programming includes:

"The Michael Irvin Podcast" premiered October 1, 2020
Hall of Famer Michael Irvin ? The Crown Prince of Planet Texas ? has been entertaining on the NFL gridiron as well as the NFL television stage with his hilarious takes and honest conversations for years. Now he'll bring the biggest names in sports and entertainment to the Podcast World! The MIP will have a no holds barred approach to news, pop culture, football analysis, and of course a lil controversy. Make sure you catch Michaedl's "88 Seconds" RANT at the end of every podcast!

"All Balls, All Sports" premiered September 8, 2020
From the NFL and college sports to boxing, racing and beyond, comedian Adam Carolla is joined daily by sports aficionado Jeff Cesario as they dive deep into the wide world of sports. Featuring hall-of-fame athletes, expert analysts and fan interaction, Adam brings his sense of humor to a more casual conversation about sports, akin to friends chatting over a beer. All Balls

"CMI: The Chris Myers Interview" premiered August 26, 2020
For more than three decades, Chris Myers has covered the biggest events in sports and has interviewed its most important personalities. From the World Series to Super Bowls, Chris was there and continues to be there. Join him for revealing conversation with elite athletes, hall of famers and people you know in the world of sports!

About PodcastOne
PodcastOne is a leading advertiser-supported podcast company, offering a 360-degree solution for both content creators and advertisers, including content development, brand integration and distribution.  Acquired by LiveXLive Media in 2020, the two entities have subsequently teamed to create a new video podcast (Vodcast) network under the LiveXLive umbrella.  Amassing more than 2.8 billion downloads annually, the network produces 400+ episodes weekly across a stable of hundreds of top podcast programs, including influencer talent like Adam Carolla, Shaquille O'Neal, Steve Austin, Erin Brockovitch, Amanda Cerney & Jacqueline Fernandez, Kaitlyn Bristowe, Tip "T.I." Harris, Demi Burnett, Autumn Calabrese, Armando "Pitbull" Perez, Jordan Harbinger, Spencer and Heidi Pratt, Heather Dubrow, The LadyGang, Dr. Drew, Chael Sonnen, Rich Eisen, and hundreds more. Its shows are distributed across its own platform as well as LiveXLive's owned-and-operated channels on mobile, mobile web, desktop and SmartTV's.  PodcastOne is the brainchild of Radio Hall of Famer, Norm Pattiz, also the founder of Network Radio-giant, Westwood One. PodcastOne is a wholly-owned subsidiary of LiveXLive Media, Inc. (NASDAQ: LIVX). 

About LiveXLive Media, Inc.
Headquartered in Los Angeles, California, LiveXLive Media, Inc. (NASDAQ: LIVX) (the "Company") (pronounced Live "by" Live) is a global platform for live stream and on-demand audio, video and podcast content in music, comedy, and pop culture. LiveXLive, which has streamed over 1200 artists since January 2020, has become a go-to partner for the world's top artists and celebrity voices as well as music festivals concerts, including Rock in Rio, EDC Las Vegas, and many others. In April 2020, LiveXLive produced its first 48-hour music festival called "Music Lives" with tremendous success as it earned over 50 million views and over 5 billion views for #musiclives on TikTok on 100+ performances. LiveXLive's library of global events, video-audio podcasts and original shows are also available on Amazon, Apple TV, Roku and Samsung TVs in addition to its own app, destination site and social channels. The Company's wholly-owned subsidiary, PodcastOne, generates more than 2.1 billion downloads annually across more than 300 podcasts. For more information, visit www.livexlive.com and follow us on Facebook, Instagram, TikTok, Twitter at @livexlive, and YouTube.

Forward-Looking Statements
All statements other than statements of historical facts contained in this press release are "forward-looking statements," which may often, but not always, be identified by the use of such words as "may," "might," "will," "will likely result," "would," "should," "estimate," "plan," "project," "forecast," "intend," "expect," "anticipate," "believe," "seek," "continue," "target" or the negative of such terms or other similar expressions. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including: the Company's reliance on one key customer for a substantial percentage of its revenue; the Company's ability to consummate any proposed financing or acquisition and the timing of the closing of such proposed transactions, including the risks that a condition to closing would not be satisfied within the expected timeframe or at all or that the closing of any proposed transaction will not occur; the Company's ability to continue as a going concern; the Company's ability to attract, maintain and increase the number of its users and paid subscribers; the Company identifying, acquiring, securing and developing content; the Company's ability to maintain compliance with certain financial and other covenants; the Company successfully implementing its growth strategy, including relating to its technology platforms and applications; management's relationships with industry stakeholders; the effects of the global Covid-19 pandemic; changes in economic conditions; competition; risks and uncertainties applicable to the businesses of the Company's subsidiaries; and other risks, uncertainties and factors including, but not limited to, those described in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2020, filed with the U.S. Securities and Exchange Commission (the "SEC") on June 26, 2020, Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, filed with the SEC on August 14, 2020, and in the Company's other filings and submissions with the SEC. These forward-looking statements speak only as of the date hereof and the Company disclaims any obligations to update these statements, except as may be required by law. The Company intends that all forward-looking statements be subject to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.    

PodcastOne
310.246.4600
[email protected]

LiveXLive / PodcastOne IR Contact:
310.529.2500
[email protected]

 

SOURCE LiveXLive Media, Inc.


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: